Abstract: The invention relates to plant protection compositions based on a two-component system of plant fungicides, one of which is 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole and the other is Mancozeb, which is an [ethylenebis(dithiocarbamato)]manganese complex with [ethylene-bis(dithiocarbamato)]zinc of the formula II ##STR1## In the range from 1:3 to 1:100 the disclosed mixtures display enhanced fungicidal activities.

Abstract: Alkylamide derivatives having the formula, These compounds have a strong antiulcer action depend on histamine H.sub.2 -receptor antagonistic action and a cytoprotective action upon gastric mucous membrance.

Abstract: A method and a composition for attracting bark beetles, particularly southern pine beetles, and suppressing their further development to halt destructive forest infestations.

Abstract: A fungicidal composition and method for the protection of vines against disease are provided. The composition which is applied to vines contains as active material a mixture of 1 part by weight of a monoester salt of a phosphorous acid of the formula ##STR1## in which R is an alkyl radical having 2 to 4 carbon atomsMe is an alkali metal, alkaline earth, or aluminum atomn is a whole number from 1 to 3 equal to the valence of Meand from 0.05 to 8 parts of at least one contact fungicide selected from the group consisting of compounds having a base of copper, the metallic ethylene bisdithiocarbamates, and the derivatives of phthalimide.

Abstract: Dithiocarbamic compounds, administered about 0.5 to about 6 hours after Pt compounds, have been found to counter the toxicity of the platinum in multicellular organisms (e.g. mammals). For example, neoplastic growths in mammals can be treated with cis-diamine or cis-diammine Pt(II) complexes with greatly lessened risk of nephrotoxicity, bone marrow toxicity, or damage to the digestive system of the mammal, provided the dithiocarbamic compound is timely (and preferably parenterally) administered. Particularly effective dithiocarbamic compounds are monomeric (e.g. ##STR1## where M is a pharmaceutically acceptable cation and R.sup.1 and R.sup.2 are lower aliphatic (or cycloaliphatic or heterocycloaliphatic groups) or, less preferably, dimeric, e.g. ##STR2## wherein R.sup.1 and R.sup.2 are as defined previously, and R.sup.3 and R.sup.4 are defined in the same manner as R.sup.1 and R.sup.2.

Abstract: Dithiocarbamic compounds, administered about 0.5 to about 6 hours after Pt compounds, have been found to counter the toxicity of the platinum in multi-cellular organisms (e.g. mammals). For example, neoplastic growths in mammals can be treated with cis-diamine or cis-diamine Pt(II) complexes with greatly lessened risk of nephrotoxicity, bone marrow toxicity, or damage to the digestive system of the mammal, provided the dithiocarbamic compound is timely (and preferably parenterally) administered. Particularly effective dithiocarbamic compounds are monomeric (e.g. ##STR1## where M is a pharmaceutically acceptable cation and R.sup.1 and R.sup.2 are lower aliphatic (or cycloaliphatic or heterocycloaliphatic groups) or, less preferably, dimeric, e.g. ##STR2## wherein R.sup.1 and R.sup.2 are as defined previously, and R.sup.3 and R.sup.4 are defined in the same manner as R.sup.1 and R.sup.2.